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background: Myocardial fibrosis has been implicated as a central component in the pathophysiology of heart failure with preserved ejection 
fraction. However, limited in vivo data exist regarding the degree of myocardial fibrosis in humans with HFpEF. Furthermore, no previous study has 
yet compared diffuse myocardial fibrosis in human HFpEF vs. HFrEF using cardiac MRI T1 measurements, a validated technique to assess myocardial 
fibrosis.
Methods: We prospectively studied male subjects without HF (n=30), with HFpEF (n=24) and HFrEF (n=10), without evidence of myocardial 
infarction on delayed enhancement imaging. We assessed diffuse myocardial fibrosis as the extracellular volume fraction (ECV) from pre- and post-
gadolinium myocardial T1 measurements from Look-Locker sequences. The slope of the linear relationship between the myocardial R1 (LV wall) 
versus blood for the pre-Gd R1 measurement and several post-Gd time points provided an estimate of the partition coefficient for Gd, lambda, which 
was used to compute the extracellular volume fraction (ECV). We excluded subjects with evidence of myocardial infarctions by delayed enhancement 
imaging.
results: Mean age was similar between the groups (P=0.21). In univariate analyses, HFrEF (β=9.3; P=0.001) but not HFpEF (β=3.1; P=0.15) 
was associated with a greater ECV. Mean ECV in subjects without HF, with HFpEF and HFrEF was 25.4, 28.5 and 34.8, respectively. In a multivariate 
model that adjusted for age, estimated glomerular filtration rate, diabetes mellitus, systolic blood pressure, LDL- and HDL-cholesterol, HFpEF 
was associated with an increase in ECV of 5.42 (95%CI=0.42 to 10.4; P=0.03), whereas HFrEF was associated with an increase in ECV of 10.8 
(95%CI=5.0-16.6; P<0.001)
conclusions: Although both HFpEF and HFrEF are associated with increased diffuse myocardial fibrosis relative to males without HF, those with 
HFrEF demonstrate a much greater increase than those with HFpEF. Our findings from a male population challenge the evolving view that HFpEF is 
associated with marked myocardial fibrosis. Fibrosis is however, a prominent feature of HFrEF even in the absence of myocardial infarction.
